Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumo 23 Booster in Prevnar-Primed Children
NCT00594347Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2007
- Primary completion
- Mar 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Pneumo 23 in pneumococcal infection, sponsored by Sanofi. Started Nov 2007; status: completed.
02
Drugs
Pneumo 23
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00594347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594347.